High-content imaging of Mycobacterium tuberculosis-infected macrophages: An in vitro model for tuberculosis drug discovery

Future Medicinal Chemistry

Volumn 2, Issue 8, 2010, Pages 1283-1293

  Christophe, Thierry ^a   Ewann, Fanny ^b   Jeon, Hee Kyoung ^a   Cechetto, Jonathan ^a   Brodin, Priscille ^b  

^a Screening Technologies and Pharmacology   (South Korea)

^b Biology of Intracellular Pathogens Inserm Avenir   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIUM DETECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CYTOTOXICITY; HUMAN; IN VITRO STUDY; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; CELL LINE; DRUG DISCOVERY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; SMALL MOLECULE LIBRARIES; TUBERCULOSIS;

EID: 77956026737     PISSN: 17568919     EISSN: None     Source Type: Journal    
DOI: 10.4155/fmc.10.223     Document Type: Review

References (19)

1. Balganesh TS, Alzari PM, Cole ST. Rising standards for tuberculosis drug development. Trends Pharmacol. Sci. 29(11), 576-581 (2008).
2. Nguyen L, Pieters J. The trojan horse: survival tactics of pathogenic mycobacteria in macrophages. Trends Cell Biol. 15(5), 269-276 (2005).
3. Murphy DJ, Brown JR. Novel drug target strategies against Mycobacterium tuberculosis. Curr. Opin. Microbiol. 11(5), 422-427 (2008).
4. Arain TM, Resconi AE, Singh DC, Stover CK. Reporter gene technology to assess activity of antimycobacterial agents in macrophages. Antimicrob. Agents Chemother. 40(6), 1542-1544 (1996).
5. Abraham VC, Taylor DL, Haskins JR. High content screening applied to large-scale cell biology. Trends Biotechnol. 22(1), 15-22 (2004).
6. Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J. 9(2), 219-228 (1995).
7. Agaisse H, Burrack LS, Philips JA, Rubin EJ, Perrimon N, Higgins DE. Genome-wide RNAi screen for host factors required for intracellular bacterial infection. Science 309(5738), 1248-1251 (2005).
8. Philips JA, Rubin EJ, Perrimon N. Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection. Science 309(5738), 1251-1253 (2005).
9. Moon H, Genovesio A. IM.Grid, a grid computing approach for image mining of high throughput-high content screening. In: The 9th IEEE/ACM International Conference on Grid Computing. Tsukuba, Japan, 29 September-1 October 2008.
10. Christophe T, Jackson M, Jeon HK et al. High-content screening identifies decaprenyl-phosphoribose 2́ epimerase as a target for intracellular antimycobacterial inhibitors. PLoS Pathog. 5(10), e1000645 (2009).
11. Fenistein D, Lenseigne B, Christophe T, Brodin P, Genovesio A. A fast fully automated cell segmentation algorithm for high-throughput and high-content screening. Cytometry A 73(10) 958-964 (2008).
12. Lenseigne B, Brodin P, Jeon HK, Christophe T, Genovesio A. Support vector machines for automatic detection of tuberculosis bacteria in confocal microscopy images. Presented at: ISBI'07. Metro Washington DC, USA, 12-15 April 2007.
13. Jayaswal S, Kamal MA, Dua R et al. Identification of host-dependent survival factors for intracellular Mycobacterium tuberculosis through an siRNA screen. PLoS Pathog. 6(4), e1000839 (2010).
14. Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high-throughput screening assays. J. Biomol. Screen. 4(2), 67-73 (1999).
15. Tailleux L, Neyrolles O, Honore-Bouakline S et al. Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells. J. Immunol. 170(4), 1939-1948 (2003).
16. Bermudez LE, Goodman J. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect. Immun. 64(4), 1400-1406 (1996).
17. Neyrolles O, Hernandez-Pando R, Pietri-Rouxel F et al. Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS ONE 1(1), e43 (2006).
18. Barry CE 3rd, Boshoff HI, Dartois V et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7(12), 845-855 (2009).
19. Peyron P, Vaubourgeix J, Poquet Y et al. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog 4(11), e1000204 (2008).